• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在专门的姑息治疗病房住院的晚期癌症患者的姑息性镇静。

Palliative sedation in advanced cancer patients hospitalized in a specialized palliative care unit.

机构信息

Clinica Somer, Calle 38 No. 54 a 35, Rionegro, Colombia.

Medicáncer, Carrera 51 D No. 67-60, Medellin, Colombia.

出版信息

Support Care Cancer. 2018 Sep;26(9):3173-3180. doi: 10.1007/s00520-018-4164-7. Epub 2018 Mar 29.

DOI:10.1007/s00520-018-4164-7
PMID:29600413
Abstract

PURPOSE

To describe the practice of palliative sedation (PS) in patients with advanced cancer in a specialized palliative care (PC) unit in Colombia.

METHODS

Descriptive prospective study including all adults with cancer hospitalized under PS in a cancer institute between January and July 2015 in Colombia. Variables examined were diagnosis, physical functioning, symptoms at the start of sedation, medications and dosages used, and type, level, and time of sedation. Descriptive and correlational statistics were obtained.

RESULTS

Sixty-six patients were included, 70% of which were women. The patients had an average age of 61 years (range 24-87), and 74% had a Karnofsky Index (KI) of 50% or less. The most frequent diagnosis was breast cancer (22%), and 82% had metastatic cancer. The prevalence of palliative sedation was 2% and the most common symptoms indicating it were dyspnea (59%), delirium (45%), and pain (32%). All patients received midazolam as a sedative. The average time between the interval start and culmination of sedation was 44 h. There was a significant and inverse relationship between functionality and time under sedation.

CONCLUSIONS

Palliative sedation is a valid therapeutic option for refractory symptoms causing suffering. The results correspond to international reports and guidelines, which suggests that PS is tailored to the needs of the individual patient while maintaining a high scientific standard, even in a context where PC is under development. However, further development of strategies and clear indications towards the use of PS in Colombia are needed, given its still scarce use.

摘要

目的

描述在哥伦比亚一家专门的姑息治疗(PC)病房中,对晚期癌症患者进行姑息性镇静(PS)的实践。

方法

这是一项描述性的前瞻性研究,纳入了 2015 年 1 月至 7 月期间在哥伦比亚某癌症研究所住院并接受 PS 的所有成年癌症患者。检查的变量包括诊断、身体功能、镇静开始时的症状、使用的药物和剂量,以及镇静的类型、水平和时间。采用描述性和相关性统计方法进行分析。

结果

共纳入 66 例患者,其中 70%为女性。患者的平均年龄为 61 岁(范围为 24-87 岁),74%的 Karnofsky 指数(KI)小于或等于 50%。最常见的诊断是乳腺癌(22%),82%的患者有转移性癌症。姑息性镇静的发生率为 2%,最常见的提示症状是呼吸困难(59%)、谵妄(45%)和疼痛(32%)。所有患者均接受咪达唑仑镇静。镇静开始到结束的平均时间间隔为 44 小时。功能与镇静时间之间存在显著的负相关关系。

结论

姑息性镇静是治疗导致痛苦的难治性症状的有效治疗选择。结果与国际报告和指南一致,表明 PS 是根据个体患者的需求量身定制的,同时保持了较高的科学标准,即使在 PC 发展的背景下也是如此。然而,鉴于 PS 在哥伦比亚的使用仍然较少,仍需要进一步制定策略并明确 PS 的使用指征。

相似文献

1
Palliative sedation in advanced cancer patients hospitalized in a specialized palliative care unit.在专门的姑息治疗病房住院的晚期癌症患者的姑息性镇静。
Support Care Cancer. 2018 Sep;26(9):3173-3180. doi: 10.1007/s00520-018-4164-7. Epub 2018 Mar 29.
2
Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.在一家三级癌症治疗中心对晚期癌症患者进行持续姑息性镇静治疗。
BMC Palliat Care. 2018 Jan 4;17(1):13. doi: 10.1186/s12904-017-0264-2.
3
[Palliative sedation at a university palliative care unit--a descriptive analysis].[大学姑息治疗病房的姑息性镇静——描述性分析]
Dtsch Med Wochenschr. 2016 Apr;141(8):e60-6. doi: 10.1055/s-0041-106460. Epub 2016 Apr 14.
4
Palliative sedation in patients with advanced cancer followed at home: a prospective study.晚期癌症患者居家随访中的姑息性镇静:一项前瞻性研究。
J Pain Symptom Manage. 2014 May;47(5):860-6. doi: 10.1016/j.jpainsymman.2013.06.019. Epub 2013 Oct 5.
5
Palliative sedation in end-of-life care and survival: a systematic review.终末期关怀中的缓和性镇静治疗与生存:系统综述。
J Clin Oncol. 2012 Apr 20;30(12):1378-83. doi: 10.1200/JCO.2011.37.3795. Epub 2012 Mar 12.
6
Sedation at the end of life - a nation-wide study in palliative care units in Austria.临终镇静——奥地利姑息治疗病房的一项全国性研究。
BMC Palliat Care. 2016 May 14;15:50. doi: 10.1186/s12904-016-0121-8.
7
'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit.“姑息性镇静”?一项关于姑息治疗病房连续给予镇静剂的使用和标签的回顾性队列研究。
Palliat Med. 2018 Jul;32(7):1189-1197. doi: 10.1177/0269216318764095. Epub 2018 Mar 20.
8
Ethical validity of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan.姑息性镇静治疗的伦理有效性:一项在日本专科姑息治疗病房开展的多中心、前瞻性观察性研究。
J Pain Symptom Manage. 2005 Oct;30(4):308-19. doi: 10.1016/j.jpainsymman.2005.03.016.
9
Palliative Sedation at the End of Life: Patterns of Use in an Israeli Hospice.临终时的姑息性镇静:以色列一家临终关怀医院的使用模式
Am J Hosp Palliat Care. 2016 May;33(4):369-73. doi: 10.1177/1049909115572991. Epub 2015 Feb 20.
10
The quality of palliative sedation in end-stage disease: audit from a department of oncology and haematology.终末期疾病姑息镇静治疗的质量:肿瘤学和血液学系的审计。
Support Care Cancer. 2022 May;30(5):3849-3855. doi: 10.1007/s00520-021-06730-8. Epub 2022 Jan 17.

引用本文的文献

1
Frequency and predictors of palliative sedation among patients with cancer who died in a specialist inpatient palliative care unit: a retrospective study.在专科住院姑息治疗病房死亡的癌症患者中姑息性镇静的频率及预测因素:一项回顾性研究
BMC Palliat Care. 2025 May 29;24(1):153. doi: 10.1186/s12904-025-01787-2.
2
Characteristics Associated with Survival in Patients Receiving Continuous Deep Sedation in a Hospice Care Unit.临终关怀病房中接受持续深度镇静患者的生存相关特征。
J Hosp Palliat Care. 2021 Dec 1;24(4):254-260. doi: 10.14475/jhpc.2021.24.4.254.
3
Survival Outcomes in Palliative Sedation Based on Referring Versus On-Call Physician Prescription.

本文引用的文献

1
Palliative Sedation in Patients With Cancer.癌症患者的姑息性镇静
Cancer Control. 2015 Oct;22(4):433-41. doi: 10.1177/107327481502200409.
2
Palliative pharmacological sedation for terminally ill adults.晚期成年患者的姑息性药物镇静
Cochrane Database Syst Rev. 2015 Jan 2;1(1):CD010206. doi: 10.1002/14651858.CD010206.pub2.
3
Medication and monitoring in palliative sedation therapy: a systematic review and quality assessment of published guidelines.姑息性镇静治疗中的药物治疗与监测:已发表指南的系统评价与质量评估
基于转诊医生与值班医生处方的姑息性镇静治疗的生存结局。
J Clin Med. 2023 Aug 9;12(16):5187. doi: 10.3390/jcm12165187.
4
Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis.《2022年癌症患者疼痛患病率最新情况:系统文献综述与荟萃分析》
Cancers (Basel). 2023 Jan 18;15(3):591. doi: 10.3390/cancers15030591.
5
Sedation in specialized palliative care: A cross-sectional study.专科姑息治疗中的镇静:一项横断面研究。
PLoS One. 2022 Jul 8;17(7):e0270483. doi: 10.1371/journal.pone.0270483. eCollection 2022.
6
Comment on Ramos-Rincon et al. Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study. 2021, , 873.评 Ramos-Rincon 等人的《COVID-19 生命终末期关怀中的姑息性镇静:回顾性队列研究》。2021 年, ,873 页。
Medicina (Kaunas). 2022 Jan 6;58(1):82. doi: 10.3390/medicina58010082.
7
The Decision-Making Process for Palliative Sedation for Patients with Advanced Cancer-Analysis from a Systematic Review of Prospective Studies.晚期癌症患者姑息性镇静的决策过程——基于前瞻性研究系统评价的分析
Cancers (Basel). 2022 Jan 8;14(2):301. doi: 10.3390/cancers14020301.
8
How to measure the effects and potential adverse events of palliative sedation? An integrative review.如何衡量姑息性镇静的效果和潜在不良事件?一项综合综述。
Palliat Med. 2021 Feb;35(2):295-314. doi: 10.1177/0269216320974264. Epub 2020 Dec 14.
9
Identification and evaluation of observational measures for the assessment and/or monitoring of level of consciousness in adult palliative care patients: A systematic review for I-CAN-CARE.成人姑息治疗患者意识水平评估和/或监测的观察性测量指标的识别和评估:I-CAN-CARE 的系统评价。
Palliat Med. 2020 Jan;34(1):83-113. doi: 10.1177/0269216319871666. Epub 2019 Aug 22.
J Pain Symptom Manage. 2015 Apr;49(4):734-46. doi: 10.1016/j.jpainsymman.2014.08.013. Epub 2014 Sep 19.
4
ESMO Clinical Practice Guidelines for the management of refractory symptoms at the end of life and the use of palliative sedation.欧洲肿瘤内科学会(ESMO)终末期难治性症状管理及姑息性镇静使用临床实践指南。
Ann Oncol. 2014 Sep;25 Suppl 3:iii143-52. doi: 10.1093/annonc/mdu238.
5
Towards a standardised approach for evaluating guidelines and guidance documents on palliative sedation: study protocol.制定评估姑息性镇静指南和指导文件的标准化方法:研究方案。
BMC Palliat Care. 2014 Jul 7;13:34. doi: 10.1186/1472-684X-13-34. eCollection 2014.
6
Palliative sedation in patients with advanced cancer followed at home: a prospective study.晚期癌症患者居家随访中的姑息性镇静:一项前瞻性研究。
J Pain Symptom Manage. 2014 May;47(5):860-6. doi: 10.1016/j.jpainsymman.2013.06.019. Epub 2013 Oct 5.
7
Palliative sedation versus euthanasia: an ethical assessment.姑息性镇静与安乐死:伦理评估。
J Pain Symptom Manage. 2014 Jan;47(1):123-36. doi: 10.1016/j.jpainsymman.2013.03.008. Epub 2013 Jun 4.
8
Palliative sedation: reliability and validity of sedation scales.姑息性镇静:镇静评分量表的可靠性和有效性。
J Pain Symptom Manage. 2012 Nov;44(5):704-14. doi: 10.1016/j.jpainsymman.2011.11.010. Epub 2012 Jul 21.
9
Palliative sedation of terminally ill patients.晚期绝症患者的姑息性镇静
Rev Bras Anestesiol. 2012 Jul;62(4):580-92. doi: 10.1016/S0034-7094(12)70157-5.
10
Pressure during decision making of continuous sedation in end-of-life situations in Dutch general practice.荷兰普通实践中生命终末期持续镇静决策时的压力。
BMC Fam Pract. 2012 Jul 3;13:68. doi: 10.1186/1471-2296-13-68.